Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host lactoferrin receptors, primarily Intelectin-1 (ITLN1) and Low-density lipoprotein receptor-related protein 1 (LRP1), are cell surface proteins that mediate the diverse biological effects of lactoferrin, a multifunctional iron-binding glycoprotein (UniProt Q8WWA0, PubMed: 21933898). These receptors are expressed in various tissues, including the intestinal epithelium, liver, and immune cells, where they facilitate lactoferrin uptake and signal transduction. In the gut, ITLN1 is crucial for lactoferrin-mediated iron absorption, particularly in neonates, and plays a significant role in mucosal immunity by recognizing microbial glycans (PubMed: 16306324). Beyond iron transport, these receptors are involved in anti-inflammatory pathways, cell growth regulation, and host defense against pathogens. Therapeutic interest focuses on using lactoferrin or its derivatives, such as Talactoferrin alfa, to target these receptors for treating infections, chronic inflammation, and certain cancers (PubMed: 22403378). Additionally, LRP1 acts as a scavenger receptor that internalizes lactoferrin-pathogen complexes, while ITLN1 (as soluble Omentin-1) serves as an adipokine regulating insulin sensitivity.
Binding of lactoferrin to the receptor facilitates its internalization via endocytosis for iron delivery or activates intracellular signaling cascades, such as the MAPK/ERK and PI3K/Akt pathways, to modulate immune cell activity and cytokine production.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intelectin-1 (Lactoferrin receptor) (ITLN1).